Related Experiment Video
Updated: May 31, 2026
09:42
Motor Imagery Brain-Computer Interface in Rehabilitation of Upper Limb Motor Dysfunction After Stroke
Published on: September 1, 2023
Balance Rehabilitation Unit (BRU™) posturography in relapsing-remitting multiple sclerosis
Natália Kessler1, Maurício Malavasi Ganança, Cristina Freitas Ganança
1Federal University of São Paulo, Brazil. natalia_kessler@hotmail.com
Arquivos De Neuro-Psiquiatria
|July 15, 2011
Summary
Balance Rehabilitation Unit (BRU™) posturography effectively identifies balance control abnormalities in multiple sclerosis (MS) patients. This technology reveals significant differences in sway velocity and ellipse area, aiding in early detection and management.
Area of Science:
- Neurology
- Biomedical Engineering
- Rehabilitation Science
Background:
- Multiple sclerosis (MS) is a chronic neurological disease affecting balance and mobility.
- Accurate assessment of balance control is crucial for managing MS progression and patient quality of life.
Purpose of the Study:
- To investigate the efficacy of Balance Rehabilitation Unit (BRU™) posturography in evaluating balance control in patients with relapsing-remitting MS.
- To compare balance parameters between MS patients and healthy individuals.
Main Methods:
- A cross-sectional study involving 39 relapsing-remitting MS patients (Expanded Disability Status Scale [EDSS] ≤ 4) and 65 age- and gender-matched healthy controls.
- Neurotological evaluation including BRU™ posturography was performed.
- MS patients were categorized into EDSS 0-2.5 and 3-4 subgroups.
Main Results:
- Significant differences in sway velocity and ellipse area were found between MS patients (both subgroups) and controls.
- A statistically significant difference in ellipse area (condition 3) was observed between the MS EDSS 0-2.5 and MS EDSS 3-4 groups.
Conclusions:
- BRU™ posturography is a valuable tool for detecting balance control impairments in relapsing-remitting MS.
- The technology can identify abnormalities in sway velocity and ellipse area, differentiating MS patients from controls and potentially tracking disease progression.
